Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder
创伤后应激障碍失眠的认知行为治疗
基本信息
- 批准号:7384611
- 负责人:
- 金额:$ 28.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-03-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AlcoholismBehavior TherapyChronicChronic Brain InjuryClinicalCognitiveCognitive TherapyComorbid InsomniaConditionControl GroupsDailyDataDiagnostics ResearchDiseaseEffectivenessFatigueHealthMalignant NeoplasmsMeasuresMental DepressionModificationMonitorMoodsNightmareOutcomePatientsPerformancePolysomnographyPost-Traumatic Stress DisordersPrevalencePrimary InsomniaProceduresRandomizedRandomized Clinical TrialsReportingRiskSleepSleep DisordersSleep disturbancesSleeplessnessSocial AdjustmentStressSymptomsTestingTimeTraumatic Brain InjuryTraumatic Stress DisordersWeekWomanactigraphychronic painclinical effectcopingdiariesfollow-upimprovedmensizesleep onsetvigilance
项目摘要
DESCRIPTION (provided by applicant): Insomnia is the most commonly reported complaint (over 90% prevalence) of patients receiving treatment for Posttraumatic Stress Disorder (PTSD). Insomnia is not effectively treated with pharmacologic treatments and there is insufficient information on the effectiveness of behavioral therapy for sleep problems in PTSD. Recent studies have demonstrated the efficacy of Cognitive Behavior Treatment of Insomnia (CBT-I) in a variety of disorders with comorbid insomnia, which include depression, cancer, alcoholism, traumatic brain injury, and chronic pain. This application will examine if Cognitive Behavioral Therapy for Insomnia (CBT-I), developed in subjects with Primary Insomnia, will improve sleep quality in men and women with chronic Posttraumatic Stress Disorder (PTSD) who have received a first line treatment for PTSD but have persistent insomnia as defined by meeting Research Diagnostic Criteria (RDC) for Insomnia Disorder. This application will examine if CBT-I will improve sleep quality in men and women with PTSD and will gather preliminary data on whether such treatment has clinical effects that extend beyond the amelioration of sleep disturbances. We will obtain pilot data to produce an effect size estimate for CBT-I in PTSD and will develop procedures for applying this treatment in a larger randomized clinical trial. The primary objectives are to examine whether an 8 week course of CBT-I compared to a Monitor Only condition produces a significant pre-post decrease in subjective insomnia complaints and improvement in polysomnography sleep continuity in PTSD subjects and to test if the improvement in insomnia is durable. The secondary objectives are to examine whether CBT-I compared to the Monitor Only condition produces a significant pre-post improvement in other clinical outcomes including nightmares, non-sleep PTSD symptoms, mood, daytime vigor, performance on the vigilance testing, and social adjustment. All subjects will be monitored for 1 week with sleep diary, actigraphy, daily measures of fatigue and psychomotor vigilance followed by 2 nights of polysomnography before and after the 8 week treatment or monitor only period. Subjects randomized to CBT-I will have repeat assessments and procedures (except polysomnography) at 6 and 12 months post treatment to test for durability of treatment gains.
描述(由申请人提供):创伤后应激障碍(PTSD)是接受治疗的患者最常报告的主诉(患病率超过90%)。药物治疗不能有效地治疗失眠,行为治疗对PTSD睡眠问题的有效性也没有足够的信息。最近的研究已经证明了认知行为治疗失眠症(CBT-I)在多种伴有失眠症的疾病中的疗效,这些疾病包括抑郁症,癌症,酒精中毒,创伤性脑损伤和慢性疼痛。该应用程序将检查在原发性失眠受试者中开发的失眠认知行为疗法(CBT-I)是否会改善患有慢性创伤后应激障碍(PTSD)的男性和女性的睡眠质量,这些患者接受了PTSD的一线治疗,但患有持续性失眠,符合失眠症的研究诊断标准(RDC)。该应用程序将检查CBT-I是否会改善患有PTSD的男性和女性的睡眠质量,并将收集有关这种治疗是否具有超出改善睡眠障碍的临床效果的初步数据。我们将获得试点数据,以产生CBT-I在PTSD中的效应量估计,并将开发在更大的随机临床试验中应用这种治疗的程序。主要目的是检查与仅监测条件相比,CBT-I的8周疗程是否在PTSD受试者中产生主观失眠投诉的显著前后减少和多导睡眠图睡眠连续性的改善,并测试失眠的改善是否持久。次要目的是检查CBT-I与仅监测条件相比是否在其他临床结果中产生显著的前后改善,包括噩梦,非睡眠PTSD症状,情绪,白天活力,警惕测试的表现和社会适应。所有受试者将通过睡眠日记、活动记录仪、每日疲劳和精神警觉测量进行监测1周,随后在8周治疗或仅监测期之前和之后进行2晚多导睡眠图。随机分配至CBT-I组的受试者将在治疗后6个月和12个月接受重复评估和程序(多导睡眠描记术除外),以检测治疗获益的持久性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas C Neylan其他文献
Delta Sleep Response to Metyrapone in Post-Traumatic Stress Disorder
创伤后应激障碍患者对甲吡酮的δ睡眠反应
- DOI:
10.1038/sj.npp.1300215 - 发表时间:
2003-04-22 - 期刊:
- 影响因子:7.100
- 作者:
Thomas C Neylan;Maryanne Lenoci;Melissa L Maglione;Nicholas Z Rosenlicht;Thomas J Metzler;Christian Otte;Frank B Schoenfeld;Rachel Yehuda;Charles R Marmar - 通讯作者:
Charles R Marmar
The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems
双重食欲素受体拮抗剂阿戈美拉汀允许觉醒促进系统的激活
- DOI:
10.1038/npp.2015.256 - 发表时间:
2015-08-20 - 期刊:
- 影响因子:7.100
- 作者:
Gregory S Parks;Deepti R Warrier;Lars Dittrich;Michael D Schwartz;Jeremiah B Palmerston;Thomas C Neylan;Stephen R Morairty;Thomas S Kilduff - 通讯作者:
Thomas S Kilduff
Thomas C Neylan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas C Neylan', 18)}}的其他基金
Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment ofVeterans with Posttraumatic Stress Disorder (PTSD)
选择性糖皮质激素受体拮抗剂治疗患有创伤后应激障碍 (PTSD) 退伍军人的 IIa 期试验
- 批准号:
10596461 - 财政年份:2022
- 资助金额:
$ 28.37万 - 项目类别:
Improving Mind/Body Health and Functioning with Integrative Exercise
通过综合运动改善身心健康和功能
- 批准号:
10775686 - 财政年份:2016
- 资助金额:
$ 28.37万 - 项目类别:
Improving Mind/Body Health and Functioning with Integrative Exercise
通过综合运动改善身心健康和功能
- 批准号:
10359673 - 财政年份:2016
- 资助金额:
$ 28.37万 - 项目类别:
Improving Mind/Body Health and Functioning with Integrative Exercise
通过综合运动改善身心健康和功能
- 批准号:
9566850 - 财政年份:2016
- 资助金额:
$ 28.37万 - 项目类别:
Improving Mind/Body Health and Functioning with Integrative Exercise
通过综合运动改善身心健康和功能
- 批准号:
10017708 - 财政年份:2016
- 资助金额:
$ 28.37万 - 项目类别:
Improving Mind/Body Health and Functioning with Integrative Exercise
通过综合运动改善身心健康和功能
- 批准号:
9348401 - 财政年份:2016
- 资助金额:
$ 28.37万 - 项目类别:
Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder
创伤后应激障碍失眠的认知行为治疗
- 批准号:
7576886 - 财政年份:2008
- 资助金额:
$ 28.37万 - 项目类别:
Cognitive Behavioral Treatment of Insomnia in Posttraumatic Stress Disorder
创伤后应激障碍失眠的认知行为治疗
- 批准号:
7784432 - 财政年份:2008
- 资助金额:
$ 28.37万 - 项目类别:
相似海外基金
Treatment effects and predictive factors of treatment response of cognitive behavior therapy for chronic pain
认知行为疗法治疗慢性疼痛的疗效及疗效预测因素
- 批准号:
15K17298 - 财政年份:2015
- 资助金额:
$ 28.37万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
IVR-based cognitive behavior therapy for chronic low back pain
基于 IVR 的认知行为疗法治疗慢性腰痛
- 批准号:
7869661 - 财政年份:2010
- 资助金额:
$ 28.37万 - 项目类别:
IVR-based cognitive behavior therapy for chronic low back pain
基于 IVR 的认知行为疗法治疗慢性腰痛
- 批准号:
8698787 - 财政年份:2010
- 资助金额:
$ 28.37万 - 项目类别:
IVR-based cognitive behavior therapy for chronic low back pain
基于 IVR 的认知行为疗法治疗慢性腰痛
- 批准号:
8211401 - 财政年份:2010
- 资助金额:
$ 28.37万 - 项目类别:
IVR-based cognitive behavior therapy for chronic low back pain
基于 IVR 的认知行为疗法治疗慢性腰痛
- 批准号:
8598428 - 财政年份:2010
- 资助金额:
$ 28.37万 - 项目类别:
Behavior Therapy for Children with Chronic Tic Disorders
慢性抽动障碍儿童的行为治疗
- 批准号:
7268855 - 财政年份:2004
- 资助金额:
$ 28.37万 - 项目类别:
Tailored Cognitive-Behavior Therapy for Chronic Pain
针对慢性疼痛的定制认知行为疗法
- 批准号:
6736415 - 财政年份:2004
- 资助金额:
$ 28.37万 - 项目类别:
Behavior Therapy for Children with Chronic Tic Disorders
慢性抽动障碍儿童的行为治疗
- 批准号:
6937678 - 财政年份:2004
- 资助金额:
$ 28.37万 - 项目类别:
Behavior Therapy for Children with Chronic Tic Disorders
慢性抽动障碍儿童的行为治疗
- 批准号:
6768350 - 财政年份:2004
- 资助金额:
$ 28.37万 - 项目类别:
Behavior Therapy for Children with Chronic Tic Disorders
慢性抽动障碍儿童的行为治疗
- 批准号:
7093060 - 财政年份:2004
- 资助金额:
$ 28.37万 - 项目类别: